← Back to Clinical Trials
Recruiting NCT07544394

NCT07544394 Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07544394
Status Recruiting
Phase
Sponsor Kahramanmaras Sutcu Imam University
Condition Sjogren's Disease
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2026-04-20
Primary Completion 2027-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2026-04-20 with a primary completion date of 2027-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective longitudinal study will be conducted in patients diagnosed with Sjögren's disease who are followed at the rheumatology outpatient clinic of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. Demographic and clinical data will be collected from routine clinical assessments and medical records, including laboratory results obtained during standard care. Participants will undergo evaluation of pressure pain threshold using a digital algometer and complete validated questionnaires assessing fatigue, disease activity, patient-reported symptoms, anxiety and depression, pain catastrophizing, sleep quality, and physical activity level. All assessments will be performed at baseline and repeated at follow-up visits approximately 3 months later.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of Sjögren's syndrome * Age ≥ 18 years * Willingness to participate and provide written informed consent Exclusion Criteria: * Presence of severe somatic or psychiatric disorders * Presence of malignancy * Pregnancy * Refusal to participate or inability to provide written informed consent

Contact & Investigator

Central Contact

Nazli Elif Nacar, phd

✉ nelifnacar@ksu.edu.tr

📞 +90 344 40 85

Frequently Asked Questions

Who can join the NCT07544394 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sjogren's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07544394 currently recruiting?

Yes, NCT07544394 is actively recruiting participants. Contact the research team at nelifnacar@ksu.edu.tr for enrollment information.

Where is the NCT07544394 trial being conducted?

This trial is being conducted at Kahramanmaraş, Turkey (Türkiye).

Who is sponsoring the NCT07544394 clinical trial?

NCT07544394 is sponsored by Kahramanmaras Sutcu Imam University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology